DiaMedica Therapeutics Inc. Interest Payable, Current
DiaMedica Therapeutics Inc. (DMAC) had Interest Payable, Current of $73.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Balance Sheet › Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2022-11-09
- 2022-09-30: Interest Payable, Current $73.00K.
- 2022-06-30: Interest Payable, Current $88.00K.
- 2021-12-31: Interest Payable, Current $130.00K.
| Period end | Interest Payable, Current |
|---|---|
| 2022-09-30 | $73.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $88.00K 10-Q · filed 2022-08-11 |
| 2021-12-31 | $130.00K 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |